Christopher John Halyk

Christopher John Halyk is a declared insider of MediPharm Labs Corp., with filings sourced from SEDI. In total, 7 filings cover trades dated from 24 June 2024 to 9 June 2026.

Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

The newest entry dates from 16 June 2026: an option exercise, in MediPharm Labs Corp. The median gap between a trade and its publication by SEDI is 5 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.